TAKEDA PHARMACEUTICALS AMERICA, INC. — 36C26025F0003 — Federal Contract Award | GovChime

PIID: 36C26025F0003 • Signed: Nov 19, 2025AWARDDELIVERY ORDERSmall Business

ICLUSIG

Total Obligated:$28,395

Overview

Total Obligated

$28,395

Potential Value

$28,395

Transactions

Contract Details

PIID:

36C26025F0003

Award Type:

DELIVERY ORDER

Award/IDV:AWARD

Pricing Type:FIRM FIXED PRICE

Date Signed:Nov 19, 2025

Fiscal Year:2026

Period of Performance:Oct 1, 2024 - Sep 30, 2025

Potential End Date:Sep 29, 2025

Parent IDV PIID:36F79718D0586

Modification #:P00002

Performance-Based Service:NOT APPLICABLE

Financial Breakdown

Base + Exercised Options:-$27,432

Base + All Options:-$27,432

Description of Requirement

ICLUSIG

Awardee Information

Name

UEIENNFDLWFC6L1

CAGE Code3FLV7

Business SizeOTHER THAN SMALL BUSINESS

Cong. DistrictMA-07

Address

40 LANDSDOWNE ST, CAMBRIDGE, MA, 02139

Certifications

None listed

Parent Company

NameTAKEDA PHARMACEUTICALS AMERICA, INC.

UEIENNFDLWFC6L1

Agency & Location

Contracting Agency

DepartmentDepartment of Veterans Affairs

Sub-tier AgencyDepartment Of Veterans Affairs

Contracting Office260-NETWORK CONTRACT OFFICE 20 (36C260)

Funding Agency

DepartmentDepartment of Veterans Affairs

Sub-tier AgencyDepartment Of Veterans Affairs

Funding Office648-PORTLAND (00648)

Place of Performance

EARTH CITY, SAINT LOUIS, MISSOURI, 630451213, UNITED STATES

Congressional District: MO-01

Classification & Competition

Classification Codes

NAICS Code

325412

PHARMACEUTICAL PREPARATION MANUFACTURING

PSC Code

6505

DRUGS AND BIOLOGICALS

Competition Information

Extent CompetedFULL AND OPEN COMPETITION

Solicitation ProceduresSUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY

Set-Aside Type

N/A

Number of Offers1

Transaction History

Mod #	Action Date	Obligation Change	Cumulative Total	Reason
P00002	Nov 19, 2025	-$27,432	$28,395	-
P00001	Mar 13, 2025	-$41,870	$55,827	-
0	Oct 1, 2024	+$97,697	$97,697	-